Advertisement

Pharmacy

The FDA approved Nov. 14 BeiGene USA's drug, Brukinsa, designed to treat adult patients with mantle cell lymphoma who have received at least one prior therapy.

Pentec Health, a Delaware County-based compounding and specialty pharmacy, is closing its manufacturing site in Boothwyn, Pa., and laying off 73 employees, according to the Philadelphia Business Journal.

Advertisement

A breakthrough therapy to treat certain advanced blood cancers, known as chimeric antigen receptor T-cell therapy, has shown promising results — even complete remissions in some patients — but its costs aren't sustainable for hospitals, which stand to lose hundreds…

As the traditional pharmacy industry gets increasingly difficult to navigate, two of the largest retail pharmacy chains in the U.S. are trying new and starkly different approaches to remain afloat. 

Advertisement